These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2086164)

  • 1. Clinical evaluation of the imipenem/cilastatin combination in the therapy of severe infections in patients with malignant diseases.
    Cristiano P; Iovene MR; Simioli F; Pezza M; Raucci G; Lobello R
    Drugs Exp Clin Res; 1990; 16(6):293-7. PubMed ID: 2086164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evaluation of imipenem/cilastatin in the therapy of severe infections in high-risk patients.
    Cristiano P
    Drugs Exp Clin Res; 1989; 15(1):17-20. PubMed ID: 2743870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical evaluation of imipenem/cilastatin sodium in the internal medicine].
    Fukuhara H; Kusano N; Nakamura H; Kaneshima H; Irabu Y; Shimozi K; Kitukawa K; Shigeno Y; Saito A; Kakazu T
    Jpn J Antibiot; 1991 Aug; 44(8):877-85. PubMed ID: 1920813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of imipenem/cilastatin sodium in neonatal infections].
    Okura KE; Haruta T; Kanamoto T; Kobayashi Y
    Jpn J Antibiot; 1988 Nov; 41(11):1715-20. PubMed ID: 3210303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical study of imipenem/cilastatin sodium in the perinatal period].
    Yamamoto T; Yasuda J; Kanao M; Okada H
    Jpn J Antibiot; 1988 Nov; 41(11):1792-6. PubMed ID: 3210310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic evaluation of imipenem/cilastatin sodium for bacterial infections in patients with hematological diseases].
    Sawae Y; Niho Y; Harada M; Shibuya T; Okamura T; Asano Y; Taniguchi S; Murakawa M; Toyoshima T; Kozuru M
    Jpn J Antibiot; 1992 Feb; 45(2):123-35. PubMed ID: 1613965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study of the efficacy and tolerance of imipenem-cilastatin used as monotherapy for the adjuvant treatment to surgery of peritonitis. Results of a French multicenter study including 257 patients].
    Midy D; Pometan JP; Baste JC; Pajadon V
    J Chir (Paris); 1992; 129(6-7):303-8. PubMed ID: 1474112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective randomized comparison of imipenem/cilastatin and cefotaxime for treatment of lung, soft tissue, and renal infections.
    Diaz-Mitoma F; Harding GK; Louie TJ; Thomson M; James M; Ronald AR
    Rev Infect Dis; 1985; 7 Suppl 3():S452-7. PubMed ID: 3901207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetic and clinical studies on imipenem/cilastatin sodium in the perinatal period. A study of imipenem/cilastatin sodium in the perinatal co-research group].
    Matsuda S; Suzuki M; Oh K; Ishikawa M; Soma A; Takada H; Shimizu T; Makinoda S; Fujimoto S; Chimura T
    Jpn J Antibiot; 1988 Nov; 41(11):1731-41. PubMed ID: 3062205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical studies on imipenem/cilastatin sodium in the perinatal period].
    Matsuda S; Suzuki M; Oh K
    Jpn J Antibiot; 1988 Nov; 41(11):1774-7. PubMed ID: 3210307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical studies on imipenem/cilastatin sodium in perinatal use].
    Chimura T; Morisaki N; Hirayama T; Matsuo M
    Jpn J Antibiot; 1988 Nov; 41(11):1751-7. PubMed ID: 3210306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meropenem versus imipenem/cilastatin in the treatment of intra-abdominal infections.
    Brismar B; Malmborg AS; Tunevall G; Lindgren V; Bergman L; Mentzing LO; Nyström PO; Anséhn S; Bäckstrand B; Skau T
    J Antimicrob Chemother; 1995 Jan; 35(1):139-48. PubMed ID: 7768761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical experience with imipenem/cilastatin in the treatment of severe infections in general surgery].
    Mayer M; Brand J; Schlenkhoff D; Opferkuch W
    Infection; 1986; 14 Suppl 2():S160-3. PubMed ID: 3079549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical evaluation of imipenem/cilastatin sodium as a second line regimen in severe infections associated with hematologic disorders].
    Tsuda S; Nakai H; Murakami T; Seryu S; Takashima T; Tanaka S; Nakagawa H; Nishigaki H; Okuda T; Nishida K
    Jpn J Antibiot; 1991 Aug; 44(8):886-98. PubMed ID: 1920814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospitalized patients with community-acquired pneumonia in Hong Kong: a randomized study comparing imipenem/cilastatin and ceftazidime.
    Ho A; Leung R; Lai CK; Chan TH; Chan CH
    Respiration; 1997; 64(3):224-8. PubMed ID: 9154675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative clinical evaluation of imipenem/cilastatin vs. cefotaxime in treatment of severe bacterial infections.
    Stamboulian D; Argüello EA; Jasovich A; Villar O; Maglio F
    Rev Infect Dis; 1985; 7 Suppl 3():S458-62. PubMed ID: 3901208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meropenem versus imipenem/cilastatin in the treatment of hospitalized patients with skin and soft tissue infections.
    Nichols RL; Smith JW; Geckler RW; Wilson SE
    South Med J; 1995 Apr; 88(4):397-404. PubMed ID: 7716590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical studies on imipenem/cilastatin sodium in the field of obstetrics and gynecology in the perinatal period].
    Tateno M
    Jpn J Antibiot; 1988 Nov; 41(11):1786-91. PubMed ID: 3210309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of acute bacterial exacerbations of chronic obstructive pulmonary disease in hospitalised patients--a comparison of meropenem and imipenem/cilastatin. COPD Study Group.
    Hamacher J; Vogel F; Lichey J; Kohl FV; Diwok K; Wendel H; Lode H
    J Antimicrob Chemother; 1995 Jul; 36 Suppl A():121-33. PubMed ID: 8543488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic efficacy of imipenem/cilastatin sodium on respiratory tract infections in lung cancer patients].
    Yamamoto M; Ina Y; Takada K; Noda M; Morishita M; Senda Y; Torii Y; Kakihara H; Yoshikawa K; Sugiura T
    Jpn J Antibiot; 1991 Apr; 44(4):388-97. PubMed ID: 1652653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.